SHANGHAI, China, April 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2019, before the open of U.S. markets on Thursday, May 16, 2019.
111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, May 16, 2019 (7:30 PM Beijing Time on the same day).
Dial-in details for the earnings conference call are as follows:
| United States: | +1-866-519-4004 or +1-845-675-0437 |
| Hong Kong: | +852-3018-6771 |
| China: | 400-620-8038 or 800-819-0121 |
| International: | +65-6713-5090 |
| Passcode: | 9867466 |
Please dial in 15 minutes before the call is scheduled to begin and provide the passcode to join the call.
A telephone replay of the call will be available after the conclusion of the conference call until 9:59 AM ET on May 24, 2019:
| United States: | +1-855-452-5696 |
| International: | +61-2-8199-0299 |
| Passcode: | 9867466 |
A live and archived webcast of the conference call will be available on the Investor Relations section of 111’s website at http://ir.111.com.cn/.
About 111, Inc.
111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and medical services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online medical services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s New Retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.
For more information on 111, please visit: http://ir.111.com.cn/.
For more information, please contact:
111, Inc.
Ms. Monica Mu
IR Director
Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com
In U.S.
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@ChristensenIR.com
Source: 111, Inc.